3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
233
Unknown
79
Terminated
72
Recruiting
58
Active not recruiting
56
Withdrawn
23
Not yet recruiting
22
Suspended
1
Enrolling by invitation
1
Sponsor Class
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Uterine Cervical Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Muscle Invasive Bladder Urothelial Carcinoma
1
Lymphatic Metastasis
1
Gastric Cancer Peritoneal Metastases
1
Clinical Stage I Gastric Cancer AJCC v8
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Pemetrexed
2
trilaciclib
1
trastuzumab deruxtecan
1
pembrolizumab
1
lorlatinib
1
aumolertinib
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
Anterior Temporal Lobectomy
1
Afatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Carcinoma, Non-Small-Cell Lung
×
Cisplatin
×
Clear all
NCT04762459
2022-02-24
APEX
ChineseAMS
Phase 3
Enrolling by invitation
606 enrolled